Preview

Drug development & registration

Advanced search

MODERN ISSUES OF ORGANIZING RADIO PHARM PREPARATIONS PRODUCTION BASED ON ⁶⁸GA

Abstract

Functional diagnostics method (scintigraphy), connected with injection of radioactive isotopes with further getting of 2-D image by emitting radiation detection, is widely used in medicine. Scintigraphic visualization of infections and inflammation with ⁶⁸Ga-citrate is powerful diagnostic instrument for patients with inflammation or infection disease. ⁶⁸Ga is short-lived positron emitting radionuclide (half-life time is 67,6 min, positron energy is 2,92 MeV). Such characteristics allowed to get better images of other radiopharmaceuticals with ⁶⁸Ga. Benefits of the drugs, mechanism of mother radionuclide fission is described in the article, as well as equipment for ⁶⁸Ga-citrate synthesis with all the technological processes. Obtained ⁶⁸Ga-citrate is suitable for positron emission tomography diagnostics for infection disease and inflammation detection in clinical practice.

About the Authors

O. A. Melnikova
Ural State Medical University
Russian Federation


D. N. Muratov
LLC «PET-Technology»
Russian Federation


A. F. Sitnikov
LLC «PET-Technology»
Russian Federation


E. V. Shorikov
LLC «PET-Technology»
Russian Federation


D. Yu. Kobesova
LLC «PET-Technology»
Russian Federation


References

1. А.С. Лунёв, О.Е. Клементьева, А.А. Ларенков, К.А. Петросова, М.В. Жукова, Г.Е. Кодина. Экспериментальная оценка возможности применения радиофармацевтического препарата ⁶⁸Ga-цитрат для ПЭТ-визуализации воспалений // Саратовский научно-медицинский журнал. 2014. Т. 10. № 4. С. 776-781.

2. А.А. Ларенков, А.Б. Брускин, Г.Е. Кодина. Радионуклиды галлия в ядерной медицине: радиофармацевтические препараты на основе изотопа ⁶⁸Ga // Медицинская радиология и радиационная безопасность. 2011. Т. 56 (№ 5). С. 56-73.


Review

For citations:


Melnikova O.A., Muratov D.N., Sitnikov A.F., Shorikov E.V., Kobesova D.Yu. MODERN ISSUES OF ORGANIZING RADIO PHARM PREPARATIONS PRODUCTION BASED ON ⁶⁸GA. Drug development & registration. 2018;(1):134-136. (In Russ.)

Views: 674


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)